Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-006304
Filing Date
2022-04-28
Accepted
2022-04-28 16:25:28
Documents
5
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220616xdef14a.htm DEF 14A 908013
2 GRAPHIC tmb-20220616xdef14a020.jpg GRAPHIC 173597
3 GRAPHIC tmb-20220616xdef14a018.jpg GRAPHIC 127706
4 GRAPHIC tmb-20220616xdef14a017.jpg GRAPHIC 185419
5 GRAPHIC tmb-20220616xdef14a019.jpg GRAPHIC 276775
  Complete submission text file 0001558370-22-006304.txt   1960996
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39712 | Film No.: 22867056
SIC: 2834 Pharmaceutical Preparations